The Association of Costimulatory Molecules and PPAR-polymorphisms With Autoimmune Thyroid Disease in Taiwan
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Autoimmune thyroid disease is the most common organ-specific autoimmune disease. AITD include Graves' disease and Hashimoto's thyroiditis. Although the pathogenesis of AITD remains unclear, it is generally thought that the mechanisms of the disease is a complex disease in which susceptibility genes and environmental triggers act in concert to initiate the autoimmune response to the thyroid.
The initial step of thyroid autoimmunity is the activation of T cells. The activation of T cell requires two signals: firstly, thyroid follicular cells or antigen presenting cells binds to T cell receptor through antigenic HLA complex. Secondly, the activation of T cells is also required the interaction of costimulatory molecules between thyroid follicular cells and immune cells, including CTLA-4, CD 40, CD28, ICOS. PPAR- is a kind of intranuclear transcription factor, associated with adipogenesis and inflammation. Some reports showed that PPAR- polymorphism may have a protective effect from Graves' ophthalmopathy.
The goal of the study is to investigate the relationship among SNP and mRNA of costimulatory molecules and PPAR- , serum cytokine including TNF- and sIL-2R, and clinical characteristics in AITD patients. From the study, we hope to clarify the role of costimulatory molecules and PPAR- polymorphism in AITD.
| Condition |
|---|
|
AITd Patients With Different Polymorphisms |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | The Association of Costimulatory Molecules and PPAR-polymorphisms With Autoimmune Thyroid Disease in Taiwan |
| Estimated Enrollment: | 300 |
| Study Start Date: | July 2009 |
| Estimated Study Completion Date: | June 2019 |
| Groups/Cohorts |
|---|
|
Graves' disease
no intervention
|
|
Hashimoto's thyroiditis
no intervention
|
|
Healthy subjects
no intervention
|
Detailed Description:
Autoimmune thyroid disease is the most common organ-specific autoimmune disease. AITD include Graves' disease and Hashimoto's thyroiditis. Although the pathogenesis of AITD remains unclear, it is generally thought that the mechanisms of the disease is a complex disease in which susceptibility genes and environmental triggers act in concert to initiate the autoimmune response to the thyroid.
The initial step of thyroid autoimmunity is the activation of T cells. The activation of T cell requires two signals: firstly, thyroid follicular cells or antigen presenting cells binds to T cell receptor through antigenic HLA complex. Secondly, the activation of T cells is also required the interaction of costimulatory molecules between thyroid follicular cells and immune cells, including CTLA-4, CD 40, CD28, ICOS. PPAR- is a kind of intranuclear transcription factor, associated with adipogenesis and inflammation. Some reports showed that PPAR- polymorphism may have a protective effect from Graves' ophthalmopathy.
The goal of the study is to investigate the relationship among SNP and mRNA of costimulatory molecules and PPAR- , serum cytokine including TNF- and sIL-2R, and clinical characteristics in AITD patients. From the study, we hope to clarify the role of costimulatory molecules and PPAR- polymorphism in AITD.
Eligibility| Ages Eligible for Study: | 20 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
Autoimmune thyroid patients
Inclusion Criteria:
- Autoimmune thyroid patients
- patients who cut Nodular Goiter in Wanfang Hospital
Exclusion Criteria:
- none
Contacts and Locations| Taiwan | |
| Taipei Medical University - WanFang Hospital | |
| Taipei, Taiwan | |
| Principal Investigator: | Jiunn-Diann Lin | Taipei Medical University WanFang Hospital |
More Information
No publications provided
| Responsible Party: | Jiunn-Diann Lin, Division of Endocrinology and Metabolism |
| ClinicalTrials.gov Identifier: | NCT01260532 History of Changes |
| Other Study ID Numbers: | 98049 |
| Study First Received: | December 13, 2010 |
| Last Updated: | December 13, 2010 |
| Health Authority: | Taiwan: Department of Health |
Keywords provided by Taipei Medical University WanFang Hospital:
|
Autoimmune thyroid disease |
Additional relevant MeSH terms:
|
Thyroid Diseases Hashimoto Disease Endocrine System Diseases Thyroiditis, Autoimmune Thyroiditis |
ClinicalTrials.gov processed this record on May 16, 2013